---
title: "1RT Acquisition | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/265796922.md"
published_at: "2025-11-13T22:01:02.000Z"
---

# 1RT Acquisition | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EPS: As of FY2025 Q3, the actual value is USD 0.07.

EBIT: As of FY2025 Q3, the actual value is USD -1.969 M.

### Segment Revenue

-   The company has not commenced any operations and has not generated any operating revenues as of September 30, 2025.

### Operational Metrics

-   **Net Income**: For the three months ended September 30, 2025, net income was $1,398,121, primarily from interest income on marketable securities held in the Trust Account, offset by operating costs.
-   **General and Administrative Costs**: $285,197 for the three months ended September 30, 2025, and $357,464 for the nine months ended September 30, 2025.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $293,043 for the nine months ended September 30, 2025.
-   **Net Cash Used in Investing Activities**: - $172,500,000 due to investment of cash in Trust Account.
-   **Net Cash Provided by Financing Activities**: $173,534,272, primarily from proceeds from the sale of Units and Private Placement Warrants.

### Unique Metrics

-   **Interest Income**: $1,683,318 earned on marketable securities held in the Trust Account for both the three and nine months ended September 30, 2025.

### Future Outlook and Strategy

-   **Core Business Focus**: The company intends to effectuate a Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of Private Placement Warrants, shares, debt, or a combination thereof.
-   **Non-Core Business**: The company has not commenced any operations and is focused on identifying a target company for a Business Combination.

### Priority

-   The company is focused on completing a Business Combination within the specified business combination period using the funds held in the Trust Account.

### Related Stocks

- [ONCH.US - 1RT Acquisition](https://longbridge.com/en/quote/ONCH.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Biotricity｜10-Q：2026 财年 Q3 营收 3.99 百万美元 |  | [Link](https://longbridge.com/en/news/275660962.md) |
| Baxter｜8-K：2025 财年 Q4 营收 29.74 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275754681.md) |
| 易昆尼克斯｜10-K：2025 财年营收 92.17 亿美元 |  | [Link](https://longbridge.com/en/news/275659807.md) |
| Kyndryl｜8-K：2026 财年 Q3 营收 38.59 亿美元不及预期 |  | [Link](https://longbridge.com/en/news/275314941.md) |
| Vontier｜8-K：2025 财年 Q4 营收 8.09 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275749155.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.